Avalon GloboCare Corp - ALBT Enterprise Value to EBITDA Ratio

Brandmark of Avalon GloboCare (ALBT)

The medical business of Avalon GloboCare (ALBT) relies on steady demand, although sanctions risks and Asian logistics disruptions complicate component supplies. This EV/EBITDA price trend chart, which currently stands at 0.00, links these challenges to laboratory operations and cell therapy developments in the US and China. Diagnostic services currently generate revenue, while the potential of oncology therapies will become the primary growth driver in the future.

Avalon GloboCare Corporation - ALBT EV/EBITDA Multiple (period 11/23/2025 - 07/22/2026)

Metric breakdowns and analytics for Avalon GloboCare Corp (ALBT)

Summary company analytics:ALBT (Avalon GloboCare Corporation)
Product sample of Avalon GloboCare Corp.

For Avalon GloboCare (ALBT), this indicator serves as the basis for assessing the cost of capital, accounting for debt load and tax obligations. By analyzing the Enterprise Value to EBITDA ratio, an investor can see how the efficiency of laboratory diagnostics and cell therapy impacts overall capitalization, allowing for the differentiation of real business growth from temporary fluctuations in operating margins.

Competitor analysis

HCA Healthcare - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio THC (Tenet Healthcare Corporation)|Fresenius Medical Care - EV/EBITDA Multiple|Solventum Corp - Enterprise Value to Operating Income Before Depreciation Ratio|Encompass Health (EHC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation UHS|Enterprise Value to EBITDA Ratio DVA|EV/EBITDA Multiple RadNet, Inc.|Enterprise Value to EBITDA Ratio OPCH (Option Care Health)|SGRY (Surgery Partners) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Premier Health PINC|America's Best Contacts & Eyeglasses (EYE) - Company Value to EBITDA|PGNY: Enterprise Value to EBITDA Ratio|ARDT (Ardent Health Partners) - Enterprise Value to Operating Income Before Depreciation|SEM (Select Medical Holdings) - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation ASTH|Enterprise Value to EBITDA Ratio MD|USPH: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization The Pennant Group (PNTG)|ORGO - Company Value to EBITDA|EV/EBITDA Multiple NUTX (nutexhealth.com)|EV/EBITDA Multiple Auna S.A. AUNA|SBC - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Evolus, Inc. (EOLS) - Enterprise Value to EBITDA Ratio|CYH: EV/EBITDA Multiple|The Beauty Health Company - Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio MDWD|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BTMD|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization The Joint Corporation (JYNT)|DocGo, Inc (DCGO) - Enterprise Value to EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation Ratio P3 Health (PIII)|Enterprise Value to Operating Income Before Depreciation Ratio GANX (Gain Therapeutics)|EUDA Health Holdings - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple Basel Medical Group Ltd (BMGL)|CLGN: EV/EBITDA Multiple|CUPR - Total Company Value to Operating Income Before Depreciation Ratio|CCM (Concord Medical Services Holdings) - EV/EBITDA Multiple|Company Value to EBITDA ashs.com AMS|Enterprise Value to EBITDA Ratio MRM (MEDIROM)|Enterprise Value to EBITDA Ratio DIH Holding US Inc. DHAI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization carmellcosmetics.com XAGE|NIVF - Enterprise Value to EBITDA Ratio|ATIP: Enterprise Value to EBITDA Ratio|CMAX - EV/EBITDA Multiple|KDLY: EV/EBITDA Multiple|Company Value to EBITDA ModivCare (MODV)|NVOS (Novo Integrated Sciences Corp) - EV/EBITDA Multiple|sunlinkhealth.com (SSY) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio BACK (IMAC Regeneration Centers)